Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT

Okusaka, T; Ikeda, K; Kudo, M; Finn, R; Qin, SK; Han, KH; Cheng, AL; Piscaglia, F; Kobayashi, M; Sung, M; Chen, MS; Wyrwicz, L; Yoon, JH; Ren, ZG; Mody, K; Dutcus, C; Tamai, T; Ren, M; Hayato, S; Kumada, H

Okusaka, T (corresponding author), Natl Canc Ctr, Tokyo, Japan.

JOURNAL OF GASTROENTEROLOGY, 2021; 56 (6): 570

Abstract

Background REFLECT was an open-label, phase 3 study comparing the efficacy and safety of lenvatinib versus sorafenib in patients with unresectable hep......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索